TEVA PHARMACEUTICAL INDUSTRIES LTD cotiza a 41.17 USD y tiene una capitalización bursátil de $48.0B. En los últimos 12 meses ha facturado $14.1B con un margen de flujo de caja libre del 6.7%. Cotiza a 35.6 veces su flujo de caja libre (P/FCF) y a un PER de 68.0. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, …
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-01 |
|---|---|---|---|---|
| Real | — | $0.02 | $0.53 | $0.96 |
| Estimado | $0.73 | $0.11 | $0.46 | $0.64 |
| Sorpresa | — | -81.8% | +15.2% | +50.0% |
| Métrica | TEVA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 51.8% | 57.0% | -5.3% |
| Operating Margin | 12.5% | -38.6% | +51.1% |
| Net Margin | 8.2% | -33.6% | +41.7% |
| FCF Margin | 6.7% | -13.9% | +20.5% |
| ROE | 17.8% | -40.4% | +58.2% |
| ROA | 3.5% | -32.0% | +35.5% |
| Current Ratio | 1.04 | 2.84 | -1.80 |
| Debt / Equity | 2.13 | 0.28 | +1.85 |